Prakasit Sa-Ngiamwibool
Overview
Explore the profile of Prakasit Sa-Ngiamwibool including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dokduang H, Jarernrat A, Titapun A, Sitthirak S, Padthaisong S, Kittirat Y, et al.
Anticancer Res
. 2025 Jan;
45(2):579-592.
PMID: 39890181
Background/aim: Cholangiocarcinoma (CCA) is an aggressive cancer with limited effective chemotherapy and targeted therapy options. Existing cell lines and animal models only partially mimic the characteristics of the tumor, highlighting...
2.
Thanasukarn V, Srisuk T, Luvira V, Tipwaratorn T, Jareanrat A, Rattanarak K, et al.
World J Surg Oncol
. 2024 Oct;
22(1):287.
PMID: 39478620
Background: The Cholangiocarcinoma Screening and Care Program (CASCAP) has been launched since 2013 to detect early-stage cholangiocarcinoma and reduce the disease death. However, the clinical utility of the CASCAP remains...
3.
Chamadol N, Laopaiboon V, Jareanrat A, Thanasukarn V, Srisuk T, Luvira V, et al.
Heliyon
. 2024 Oct;
10(18):e38191.
PMID: 39381227
Background: Most cholangiocarcinoma (CCA) patients present with late stage of disease because of the difficulty to diagnosis at an early stage, resulting in poor survival of CCA patients. The Cholangiocarcinoma...
4.
Syms R, Wadsworth C, Kardoulaki E, Titapun A, Boonphongsathien W, Sa-Ngiamwibool P, et al.
Front Oncol
. 2024 Apr;
14:1306242.
PMID: 38651146
Intraductal T2 mapping based on a catheter receiver is proposed as a method of visualizing the extent of intraductal and periductal cholangiocarcinoma (CCA). Compared to external receivers, internal receivers provide...
5.
Khuntikeo N, Padthaisong S, Loilome W, Klanrit P, Ratchatapusit S, Techasen A, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835526
Background: The mismatch repair (MMR) system prevents DNA mutation; therefore, deficient MMR protein (dMMR) expression causes genetic alterations and microsatellite instability (MSI). dMMR is correlated with a good outcome and...
6.
Koonmee S, Sa-Ngiamwibool P, Aphivatanasiri C, Kunprom W, Intarawichian P, Bamrungkit W, et al.
Recent Results Cancer Res
. 2023 Sep;
219:91-107.
PMID: 37660332
The liver excretes bile through the biliary system, which has a complicated anatomical structure. Cholangiocarcinoma, a malignant bile duct epithelial tumor, is separated into intrahepatic and extrahepatic portions depending on...
7.
Burassakarn A, Pientong C, Tongchai P, Wongjampa W, Poosari A, Udomsin A, et al.
Front Microbiol
. 2023 May;
14:1146322.
PMID: 37180234
Recently, epidemiological evidence of high-risk human papillomavirus (hrHPV) and its association with the increasing risk of esophageal cancer (EC) have been described. However, the involvement of such a virus in...
8.
Poosari A, Nutravong T, Namwat W, Sa-Ngiamwibool P, Ungareewittaya P, Boonyanugomol W
Asian Pac J Cancer Prev
. 2023 Mar;
24(3):1073-1080.
PMID: 36974563
Objective: Esophageal cancer (EC) is a multifactorial disease and a leading cause of mortality. Epidemiological and molecular studies have provided evidence that Helicobacter pylori (H. pylori) infection is an important...
9.
Intarawichian P, Sangpaibool S, Prajumwongs P, Sa-Ngiamwibool P, Sangkhamanon S, Kunprom W, et al.
Front Oncol
. 2022 Dec;
12:1004220.
PMID: 36582790
Patients with distal cholangiocarcinoma (dCCA) generally have poor outcomes because of late presentation and diagnosis. Therefore, prognostic factors for predicting outcomes are essential to improve therapeutic strategies and quality of...
10.
Sa-Ngiamwibool P, Hamasaki M, Kinoshita Y, Matsumoto S, Sato A, Tsujimura T, et al.
Lung Cancer
. 2022 Nov;
175:27-35.
PMID: 36442384
Objectives: BAP1, CDKN2A, and NF2 are the most frequently altered genes in pleural mesotheliomas (PM). Discriminating PM from benign mesothelial proliferation (BMP) is sometimes challenging; it is well established that...